SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
GCM Grosvenor Inc. (GCMGW) trades at a trailing P/E of 0.0, forward P/E of 0.0. Trailing earnings yield is 5,000.00%, forward earnings yield 10,000.00%.
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (0.0); earnings yield beats bond yields (5,000.00%).
- Forward P/E 0.0 (down from trailing 0.0) — analysts expect earnings to grow, which would improve the valuation.
- Trailing Earnings Yield 5,000.00% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 10,000.00% as earnings recover.
Overall SharesGrow Score: 79/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — GCMGW
Valuation Multiples
P/E (TTM)0.0
Forward P/E0.0
PEG Ratio0.00
Forward PEG0.00
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.42
Forward EPS (Est.)$0.87
Book Value / Share$0.00
Revenue / Share$2.79
FCF / Share$0.00
Yields & Fair Value
Earnings Yield5,000.00%
Forward Earnings Yield10,000.00%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.00 |
$0.00 |
$-2.88K |
- |
| 2017 |
$1.86 |
$377.01M |
$74.35M |
19.7% |
| 2018 |
$1.60 |
$378.5M |
$63.69M |
16.8% |
| 2019 |
$1.50 |
$416.39M |
$60M |
14.4% |
| 2020 |
$-0.37 |
$429.98M |
$-67.63M |
-15.7% |
| 2021 |
$0.75 |
$531.59M |
$142.07M |
26.7% |
| 2022 |
$0.42 |
$446.53M |
$79.48M |
17.8% |
| 2023 |
$-0.28 |
$445M |
$12.77M |
2.9% |
| 2024 |
$0.03 |
$514.01M |
$18.7M |
3.6% |
| 2025 |
$0.42 |
$550.08M |
$45.37M |
8.2% |
